Work

Supplementary Tables 1-3 from A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Tables 1-3. Suppl. Table 1 contains the list of REDD1 inhibitors identified by computational screen and selected for study. Suppl. Table 2 contains primer sets for Q-PCR analysis. Suppl. Table 3 contains IC50 values of WM, LY294002 and AZD8055 after 24 h of incubation.

DOI: 10.1158/1535-7163.22520964.v1

Authors: Ekaterina A. Lesovaya, Alena V. Savinkova, Olga V. Morozova, Evgeniya S. Lylova, Ekaterina M. Zhidkova, Evgeny P. Kulikov, Kirill I. Kirsanov, Anna Klopot, Gleb Baida, Marianna G. Yakubovskaya, Leo I. Gordon, Ben Readhead, Joel T. Dudley, Irina Budunova

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362489830

Cites:

Cited by:

Related to: 10